A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 Weeks

Clinical trial NCT00728390 · COMPLETED

Trial details

NCT number: NCT00728390
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small Cell Neoplasm Metastasis

Start date: 2008-12-15
Primary completion: 2011-08-09
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.